Patents Assigned to Tyndall Formulation Services, LLC
  • Patent number: 11891482
    Abstract: The present disclosure relates to the field of polymer chemistry and more particularly to multiblock copolymers comprising a poly(sarcosine) block and a D,L-mixed poly(amino acid) block and uses thereof.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: February 6, 2024
    Assignee: TYNDALL FORMULATION SERVICES, LLC
    Inventors: Kevin N. Sill, Bradford T. Sullivan
  • Patent number: 11857630
    Abstract: This disclosure relates to the field of formulations of SN-38 with a poly(amino acid) copolymer and methods of making and using thereof. Compositions herein are drug products suitable for the treatment of cancer.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: January 2, 2024
    Assignee: TYNDALL FORMULATION SERVICES, LLC
    Inventors: Kevin N. Sill, Bradford T. Sullivan
  • Patent number: 11286344
    Abstract: The present disclosure relates to the field of polymer chemistry and more particularly to multiblock copolymers comprising a poly(sarcosine) block and a D,L-mixed poly(amino acid) block and uses thereof.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: March 29, 2022
    Assignee: Tyndall Formulation Services, LLC
    Inventors: Kevin N. Sill, Bradford T. Sullivan
  • Patent number: 10918619
    Abstract: This disclosure relates to the field of formulations of paclitaxel with a poly(amino acid) copolymer and methods of making and using thereof. Compositions herein are drug products suitable for the treatment of cancers.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: February 16, 2021
    Assignee: Tyndall Formulation Services, LLC
    Inventors: Kevin N. Sill, Bradford T. Sullivan
  • Patent number: 10836869
    Abstract: The present disclosure relates to the field of polymer chemistry and more particularly to multiblock copolymers comprising a poly(sarcosine) block and a D,L-mixed poly(amino acid) block and uses thereof.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: November 17, 2020
    Assignee: Tyndall Formulation Services, LLC
    Inventors: Kevin N. Sill, Bradford T. Sullivan